Lonza Group AG (LON:0QNO)
534.28
+4.28 (0.81%)
At close: Nov 21, 2025
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of 35.46 billion as of November 21, 2025. Its market cap has increased by 1.44% in one year.
Market Cap
35.46B
Enterprise Value
39.01B
Revenue
6.51B
Ranking
n/a
PE Ratio
52.71
Stock Price
534.28
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 2.30B to 35.46B, an increase of 1,439.11%. That is a compound annual growth rate of 11.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 35.46B | 4.00% |
| Dec 30, 2024 | 34.10B | 39.19% |
| Dec 29, 2023 | 24.50B | -18.81% |
| Dec 30, 2022 | 30.17B | -34.20% |
| Dec 30, 2021 | 45.85B | 30.36% |
| Dec 30, 2020 | 35.17B | 70.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 211.67B |
| GSK plc | 70.73B |
| Haleon | 32.92B |
| Smith & Nephew | 10.44B |
| ConvaTec Group | 4.61B |
| Hikma Pharmaceuticals | 3.46B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.68B |